Get started with Mizzou
Apply hereOverview
If you are a STEM professional looking to earn a bioengineering degree and start a career in a growing field, this may be the program for you. Biological engineering (or bioengineering) is one of the fastest-growing sectors of industry nationally. Bioengineering is a science-based engineering discipline that integrates engineering and biological sciences in one curriculum. Bioengineers apply scientific and engineering principles to design and develop products, systems and/or processes.
The online master's in biological engineering (non-thesis) is a course work-intensive degree program. These courses allow students to explore a range of topics, and develop new skill sets in the field of bioengineering. Students have the flexibility to customize a plan of study to choose from a variety of courses according to their interests. Students will also have the opportunity to develop research skills by completing a substantial independent project.
Quick facts
Official name
Master of science in biological engineeringCampus
Program type
Master's degreeAcademic home
College of Engineering | Department of Biomedical, Biological and Chemical EngineeringDelivery mode
100% onlineAccreditation
Higher Learning CommissionCredit hours
30Estimated cost
$29,371.80*This cost is for illustrative purposes only. Your hours and costs will differ, depending on your transfer hours, your course choices and your academic progress. See more about tuition and financial aid.
Career prospects
Bioengineers apply scientific and engineering principles to develop products, systems and/or processes to improve human and animal health, bio-resource utilization and environment protection.
Program structure
The online master’s in biological engineering is non-thesis and 100 percent online: no campus visits are required.
Students typically take two classes each semester session and finish the program in two to three years.
Course work covers
- Biomaterials engineering
- Orthopaedic biomechanics
- Biomedical imaging
- Biomolecular engineering
- Nanobiotechnology
Delivery
100% onlineCalendar system
Semester-basedTypical program length
2-3 yearsTypical course load
2 classes per semesterAccreditation
The University of Missouri is accredited by the Higher Learning Commission, one of six regional institutional accreditors in the United States.
Faculty spotlight
Anandhi Upendran's research interests include preclinical evaluation of nanoparticle-based drug delivery candidates, delineating drug resistance pathways in ovarian breast and NSCLC cancer, design, and validation of biomarkers for diabetic retinopathy. Dr. Upendran is published in many reference articles and has many patents in the industry.
Her areas of expertise are in designing pre-clinical trials for nanoparticle-based drug delivery platforms, drug and device regulatory affairs, education, and training students in biomedical innovation.
Raghuraman Kannan has been a faculty member at the University of Missouri-Columbia (Mizzou) since 2005. He leads the program on clinical translation of nanomaterials. He earned a master’s and a doctorate in chemistry. Kannan has been actively involved in the design and development of nanomedicine drugs and metal-based radioactive pharmaceuticals for more than 15 years.
As a principal investigator of National Institutes of Health-funded grants in the field of nanomedicine, Kannan has developed a library of biocompatible, non-toxic and readily injectable targeted nanoparticles for prostate, breast and pancreatic cancers. The results have been published in several peer-reviewed journals and formed the basis for several patent applications.
He is co-founder of start-up companies at Mizzou, two of which have raised million-dollar investments. Nanoparticle Biochem Inc. won the 2012 Tibbett’s award — presented at the White House — for technical innovation and economic development.